Blood on tap. Part 1. History in the making.
Emergency services around the United States are about to become part of the front lines in the race to bring to market the first blood substitute with oxygen-carrying capabilities. Take a look inside the high-tech world of biopharmaceuticals and the innovative pioneers who are chasing after a scientific holy grail; a synthetic substitute for blood. In the process, they have made and lost fortunes, advanced our understanding of the nature of blood and launched one of the biggest ethical controversies in modern medical history. As phase three clinical trials move to the prehospital arena, biotechnology firms are staking everything on the notion that they're about to change the way we treat trauma patients. They may be right.
Whitehead
Steve
S
Pridemark Paramedic Services, Arvada, CO, USA. eonflux@aol.com
D000818:Animals; D001709:Biotechnology / Q000639:trends*; D001802:Blood Substitutes / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use; D001803:Blood Transfusion / Q000639:trends; D002417:Cattle; D017326:Clinical Trials, Phase III as Topic; D004632:Emergency Medical Services / Q000639:trends*; D004638:Emergency Treatment / Q000639:trends*; D006454:Hemoglobins / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use; D006801:Humans; D007262:Infusions, Intravenous; D010108:Oxyhemoglobins / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use
D001802:Blood Substitutes; D006454:Hemoglobins; D010108:Oxyhemoglobins; C037158:polyhemoglobin